Hexarelin 3mg

Hexarelin 3 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

Hexarelin is a synthetic peptide research compound developed for advanced laboratory investigations involving peptide receptor biology, growth hormone secretagogue receptor signalling and intracellular molecular communication. Its defined molecular structure has attracted scientific interest within experimental peptide research, where investigators continue to explore receptor-mediated peptide signalling mechanisms and biochemical regulatory systems under carefully controlled laboratory conditions. This preparation contains 3 mg of lyophilized Hexarelin supplied in a sealed research vial. Independent analytical testing confirmed an assay content of 3.71 mg for this production batch. Chromatographic analysis confirmed 99.2 percent purity, while identity was independently evaluated through FTIR spectrum analysis and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.040 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its defined molecular identity, independently verified assay content and comprehensive third-party analytical documentation, Hexarelin provides researchers with a well-characterised peptide material suitable for advanced peptide investigations and controlled in vitro laboratory studies.  

Peptide Overview

Hexarelin is a synthetic peptide research compound commonly utilised in laboratory investigations involving peptide chemistry, receptor biology and intracellular molecular communication. The compound belongs to the broader field of growth hormone secretagogue peptide research and is investigated within experimental models involving receptor-mediated molecular signalling. Researchers employ Hexarelin in controlled experimental systems designed to investigate peptide-receptor interactions, intracellular signalling pathways and complex biochemical regulatory mechanisms. Its defined molecular structure and reproducible analytical characteristics allow important identity and quality parameters to be evaluated using complementary chromatographic, spectroscopic and mass spectrometric techniques. Today, Hexarelin continues to form part of experimental peptide research involving receptor biology, peptide chemistry and molecular signalling systems.  

Historical Background and Scientific Context

Growth hormone secretagogue peptides have become an established area of experimental peptide science as researchers investigate receptor-mediated signalling and molecular communication within controlled laboratory models. Advances in synthetic peptide engineering have enabled researchers to develop defined peptide structures for investigating growth hormone secretagogue receptor-associated molecular pathways. Hexarelin emerged within this broader area of peptide research and has subsequently become a recognised experimental compound for controlled investigations involving peptide receptor biology. Modern analytical technologies including chromatographic analysis, FTIR identification and mass spectrometry have significantly improved the ability to characterise peptide identity, assay content, purity and manufacturing consistency across laboratory research compounds. These analytical techniques can be complemented by bacterial endotoxin testing, microbiological analysis and elemental impurity screening to provide comprehensive batch-specific analytical documentation.  

Mechanistic Focus in Research

Within controlled laboratory environments, Hexarelin is commonly investigated in relation to peptide receptor signalling and growth hormone secretagogue receptor-associated molecular pathways. Research investigations frequently explore:

• Growth hormone secretagogue receptor research
• Peptide receptor signalling pathways
• Receptor-mediated intracellular communication
• Cellular regulatory mechanisms
• Biochemical pathway analysis
• Molecular peptide interactions
• Comparative peptide investigations
• Controlled in vitro peptide studies

These experimental models allow researchers to investigate peptide-mediated molecular mechanisms while maintaining carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each batch of Hexarelin supplied by Grail Formula undergoes comprehensive independent third-party laboratory analysis to characterise peptide identity, assay content, purity and microbiological quality. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric, microbiological and mass spectrometry techniques. Batch: GF-HEXAR3-B241

• Assay Content: 3.71 mg
• Purity: 99.2 %
• Identification by FTIR Spectrum: 994
• Identification by Retention Time: 0.0
• Molecular Ion Mass Identification: 887 Da
• Bacterial Endotoxins: 0.040 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 3.71 mg with a reported analytical uncertainty of ±0.02 mg. Purity analysis confirmed 99.2 percent purity with a reported analytical uncertainty of ±0.5 percent. FTIR spectrum analysis returned an identification result of 994 with a reported analytical uncertainty of ±5. The Certificate of Analysis reports the retention time identification result as 0.0. This value is reproduced directly from the laboratory documentation and is not interpreted or substituted with an estimated value. Mass spectrometry identified a molecular ion mass of 887 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin testing returned a result of 0.040 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide transparent batch-specific documentation of Hexarelin assay content, purity, identity, microbiological results, bacterial endotoxin levels and elemental impurity characteristics.  

Research Applications

Within controlled laboratory environments, Hexarelin may be utilised in experimental models designed to investigate peptide receptor biology, intracellular signalling pathways and molecular regulatory mechanisms. Examples of research applications include:

• Growth hormone secretagogue receptor investigations
• Peptide receptor signalling research
• Intracellular signalling investigations
• Molecular pathway analysis
• Biochemical regulation studies
• Comparative peptide investigations
• Molecular interaction research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. For this production batch, independent laboratory testing included:

• Peptide assay content determination
• Purity assessment
• FTIR spectrum identification
• Retention time analysis
• Molecular ion mass identification
• Bacterial endotoxin analysis
• Total aerobic microbial count
• Total yeast and mold count
• Comprehensive elemental impurity screening
• Complete batch-specific traceability

Independent laboratory analysis provides researchers with detailed analytical information relating directly to the tested production batch rather than relying solely on general product specifications. This approach supports analytical transparency and complete batch-specific traceability.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently analysed research compounds supported by detailed Certificates of Analysis and transparent batch-specific laboratory documentation. For Hexarelin 3 mg batch GF-HEXAR3-B241, independent analysis was performed by Liquilabs s.r.o. Czechia and the Certificate of Analysis was published on 20 September 2026. The analytical programme included assay determination, purity assessment, FTIR spectrum identification, retention time analysis, molecular ion mass identification, bacterial endotoxin testing, microbiological analysis and comprehensive elemental impurity screening. This multi-method analytical approach provides researchers with extensive independent information regarding the analytical characteristics of the tested Hexarelin research preparation.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.2 % purity confirmed by COA
• Assay content verified at 3.71 mg
• Identification evaluated by FTIR spectrum analysis
• Molecular ion mass identified at 887 Da
• Bacterial endotoxin level of 0.040 EU/mg
• Total aerobic microbial count: 0 CFU/g
• Total yeast and mold count: 0 CFU/g
• All reported elemental impurities below 0.001 ppm
• Complete batch-specific COA traceability
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.